73
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Improved monitoring dynamics through use of a tethered enzyme biosensor to detect and quantify neuron-specific enolase activity levels in biofluids

, , &
Pages 1-7 | Published online: 22 Sep 2017

References

  • Vizin T, Kos J. Gamma-enolase: a well-known tumour marker, with a less-known role in cancer. Radiol Oncol. 2015;49(3):217–226.
  • Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987;10:269–295.
  • Isgro MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol 2015;867:125–143.
  • Ahmad O, Wardlaw J, Whiteley WN. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 2012;33(1):47–54.
  • Lee SY, Choi YC, Kim JH, Kim WJ. Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope. J Neurol 2010;257(10):1708–1712.
  • Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006;67(2):203–210.
  • Stammet P, Collignon O, Hassager C, et al. Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33 degrees C and 36 degrees C. J Am Coll Cardiol 2015;65(19):2104–2114.
  • Kawata K, Liu CY, Merkel SF, Ramirez SH, Tierney RT, Langford D. Blood biomarkers for brain injury: what are we measuring? Neurosci Biobehav Rev 2016;68:460–473.
  • Wang H, Zhang X, Liu X, Liu K, Li Y, Xu H. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer. J Cancer Res Ther 2016;12(1):355–358.
  • Hu Q, Xiao P, Li J, Yu P. A retrospective analysis of serum tumor markers found in non-small cell lung cancer. J Cancer Res Ther 2016;12(1):117–120.
  • Riley RD, Heney D, Jones DR, et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004;10(1 Pt 1):4–12.
  • Gerbitz KD, Summer J, Thallemer J. Brain-specific proteins: solid-phase immunobioluminescence assay for neuron-specific enolase in human plasma. Clin Chem 1984;30(3):382–386.
  • Mercer DW, Virji MA, Barry GE, Piper ML. New solid-phase enzyme immunoassay of neuron-specific enolase in serum: effect of storage temperature, lipemia, icterus, and hemolysis. Clin Chem 1990;36(8 Pt 1):1519.
  • Kimura S, Uchikawa H, Yamamoto R, Kato K. Practicable enzyme immunoassay for neuron-specific enolase in human serum. J Appl Biochem 1984;6(5–6):319–324.
  • Kimura S, Uchikawa H, Yamamoto R, Kato K. Two-site column enzyme immunoassay for neuron-specific enolase (NSE) in human serum using monoclonal antibodies. J Immunol Methods 1986;94(1–2):51–55.
  • Viallard JL, Ven Murthy MR, Dastugue B. Rapid electrophoretic determination of neuron-specific enolase isoenzymes in serum. Clin Chem 1986;32(4):593–597.
  • Torsetnes SB, Lovbak SG, Claus C, et al. Immunocapture and LC-MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum. J Chromatogr B Analyt Technol Biomed Life Sci 2013;929:125–132.
  • Johnsson P, Blomquist S, Luhrs C, et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 2000;69(3):750–754.
  • Thelin EP, Jeppsson E, Frostell A, et al. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit Care 2016;20:285.
  • Wevers RA, Jacobs AA, Hommes OR. A bioluminescent assay for enolase (EC 4.2.1.11) activity in human serum and cerebrospinal fluid. Clin Chim Acta 1983;135(2):159–168.
  • Viallard JL, Murthy MR, Betail G, Dastugue B. Determination of serum neuron-specific enolase by differential immunocapture. Clin Chim Acta 1986;161(1):1–10.
  • Cohen R, Lata JP, Lee Y, et al. Use of tethered enzymes as a platform technology for rapid analyte detection. PLoS One 2015;10(11):e0142326.
  • Mukai C, Gao L, Nelson JL, et al. Biomimicry promotes the efficiency of a 10-step sequential enzymatic reaction on nanoparticles, converting glucose to lactate. Angew Chem Int Ed Engl. 2017. 56(1):235–238
  • Griffiths HR, Dias IH, Willetts RS, Devitt A. Redox regulation of protein damage in plasma. Redox Biol. 2014;2:430–435.
  • Kushnir MM. Are samples in your freezer still good for biomarker discovery? Am J Clin Pathol 2013;140(3):287–288.
  • Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci 2003;21(3–4):171–176.
  • Takayama K, Taguchi A, Yakushiji F, Hayashi Y. Identification of a degrading enzyme in human serum that hydrolyzes a C-terminal core sequence of neuromedin U. Biopolymers 2016;106(4):440–445.
  • Feng L, Zhao Y, Zhao H, Shao Z. Effects of storage time and temperature on coagulation tests and factors in fresh plasma. Sci Rep 2014;4:3868.
  • Wilkinson JH, Qureshi AR. Catabolism of plasma enzymes, as studied with 125I-labeled lactate dehydrogenase-1 in the rabbit. Clin Chem 1976;22(8):1269–1276.
  • Gotoh Y, Hashimoto K, Tada K. Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma. Tohoku J Exp Med 1986;149(1):67–72.
  • Lata JP, Gao L, Mukai C, et al. Effects of nanoparticle size on multilayer formation and kinetics of tethered enzymes. Bioconjug Chem 2015;26(9):1931–1938.